Markets Stocks Economy Crypto Earnings Banking Energy
Home› Stocks› Feature
Stocks · Exclusive

BofA cuts Enovix to underperform, slashes price target to $1

BofA cuts Enovix to underperform, slashes price target to $1
Stocks · 2026
Photo · Eleanor Whitfield for Daily Digest Invest
By Eleanor Whitfield Markets Editor-in-Chief Nov 18, 2026 4 min read

Bank of America Securities has turned more cautious on battery maker Enovix, downgrading the stock to underperform and cutting its price target sharply to $1 from $5. The move comes after the bank removed expected smartphone revenue from its financial model, a significant shift in how it views the company's near-term prospects.

In a note sent to clients Wednesday, BofA analysts said Enovix shares could remain under pressure until the company rebuilds credibility in two newer markets: defense and smart eyewear. The downgrade signals that Wall Street is losing patience with the company's smartphone ambitions, at least for now.

Why smartphones are out of the picture

Enovix makes advanced lithium-ion batteries with a unique architecture that packs more energy into a smaller space. The company had long targeted smartphones as a key growth driver, hoping its high-energy-density cells would win over major handset makers. But BofA now assumes little near-term contribution from that segment while the product goes through qualification—the lengthy process where a customer tests and formally approves a component for use in its devices.

Qualification is a standard hurdle in the electronics industry, but it can take months or even years, and there is no guarantee of success. For a company like Enovix, which is still working toward profitability, delays in a marquee market can weigh heavily on revenue forecasts and investor sentiment.

The bank's decision to strip out smartphone revenue entirely suggests it sees limited visibility on when—or if—those deals will close. That is a notable change from earlier optimism and helps explain the dramatic cut in the price target.

Defense and smart eyewear take center stage

With smartphones pushed to the back burner, BofA is pointing to defense and smart eyewear as the more immediate opportunities. Defense contracts, in particular, are seen as a nearer-term engine. But these programs come with their own challenges. Some require compliance with strict military specifications, and orders can be lumpy or subject to government budget cycles.

Smart eyewear—think augmented-reality glasses and similar wearable devices—is another emerging market where Enovix's compact, high-capacity batteries could find a niche. However, this is still an early-stage category, and volumes are unlikely to move the needle in the near term.

The pivot away from smartphones is a strategic shift that investors will be watching closely. The company will need to show tangible progress in these newer areas to rebuild confidence, especially after a downgrade of this magnitude.

What it means for investors

For everyday investors, this downgrade is a reminder that early-stage tech companies can be highly sensitive to changes in analyst expectations. A price target cut of this size—from $5 to $1—reflects a major reassessment of the company's revenue potential, not just a minor tweak.

Enovix shares have already been volatile, and the stock could stay under pressure until the company delivers concrete news on defense or smart eyewear contracts. The qualification process for smartphones is a wildcard; if it resolves positively, it could reignite interest, but BofA is clearly not banking on that.

Investors should also consider the broader context. The battery sector is competitive, with giants like CATL pushing into new business models and other players vying for market share. Enovix's differentiated technology could still find a home, but the path to meaningful revenue appears longer and more uncertain than previously thought.

For those holding the stock, the key metrics to watch are any announcements about defense contract wins, smart eyewear partnerships, or updates on smartphone qualification. Until then, the stock may trade more on speculation than fundamentals.

This downgrade also echoes a broader theme in the market: companies that pivot their strategies often face a credibility gap. As seen with Stem's recent strategic pivot, investors can be unforgiving when growth assumptions are reset. Similarly, Nvidia's recent earnings beat shows how strong execution can offset risks, but Enovix has yet to prove that in its new focus areas.

In the end, BofA's move is a cautionary signal. It doesn't mean Enovix is doomed, but it does mean the bar for positive surprises is now higher. Investors should weigh the potential upside in defense and smart eyewear against the very real possibility of further delays.

More from this story

Next article · Don't miss

Anthropic's $1.4 trillion IPO: growth story meets hefty price tag

Anthropic is set to price its IPO this week, with bankers floating a $1.4 trillion valuation. The high price tag raises the bar for growth, and early investors face lockup expirations and a first earnings report that could test confidence.

Read the story →
Anthropic's $1.4 trillion IPO: growth story meets hefty price tag